Multi-institutional European single-arm phase II trial of pazopanib in advanced malignant/dedifferentiated solitary fibrous tumors (SFT): A collaborative Spanish (GEIS), Italian (ISG), and French (FSG) sarcoma groups study.

Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072

Kasper, B.
Sleijfer, S.
Litiere, S.
Marreaud, S.
Verweij, J.
Hodge, R.A.
Bauer, S.
Kerst, J.M.
Graaf, W.T.A. van der

January 2014

BACKGROUND: Pazopanib recently received approval for the treatment of certain soft tissue sarcoma (S...

Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

Sleijfer, Stefan
Ray-Coquard, I
Papai, Z
le Cesne, A
Scurr, M
Schoffski, P
Collin, F
Pandite, L
Marreaud, S
De Brauwer, A
Glabbeke, M
Verweij, Jaap
Blay, JY

January 2009

Purpose Given the importance of angiogenesis in soft tissue sarcoma (STS), pazopanib, an oral angiog...

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study

SEZGİN GÖKSU, SEMA
PAYDAŞ, SEMRA
Akgul, Fahri
Derin, Sumeyye
Turhal, Serdar
Artac, Mehmet
Dal, Pinar
Sunar, Veli
Seker, Mehmet Metin
Gunaydin, Ulug Mutlu
Ozveren, Ahmet
Bahceci, Aykut
Sakalar, Teoman
Sahin, Suleyman
Koral, Lokman
Acar, Ramazan
Unal, Olcun Umit
Besiroglu, Mehmet
Erdem, Dilek
Demir, Hacer
Ozkul, Ozlem
Sakin, Abdullah
Gumusay, Ozge
Cinkir, Havva Yesil
Menekse, Serkan
Guc, Zeynep Gulsum
Karaca, Mustafa
Demiray, Atike Gokcen
Ozyukseler, Deniz Tataroglu
Erol, Cihan
Yekeduz, Emre
Ergun, Yakup
BİLİCİ, Ahmet
Koca, Sinan
Karaagac, Mustafa
Aydin, Sabin Goktas
Eraslan, Emrah
Kaplan, Muhammed Ali
Ocak, Birol

September 2023

Aim: Description of patient characteristics, effectiveness and safety in Turkish patients treated wi...

International single-arm phase II trial of pazopanib in advanced extraskeletal myxoid chondrosarcoma: A Collaborative Spanish (GEIS), Italian (ISG) and French (FSG) Sarcoma Groups study.

June 2017

none20sinoneSilvia Stacchiotti; Stefano Ferrari; Andres Redondo; Emanuela Palmerini; Nadia Hindi; M....

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial

Martin-Broto, Javier
Stacchiotti, Silvia
Lopez-Pousa, Antonio
Redondo, Andres
Bernabeu, Daniel
de Alava, Enrique
Casali, Paolo G
Italiano, Antoine
Gutierrez, Antonio
Moura, David S
Peña-Chilet, Maria
Diaz-Martin, Juan
Biscuola, Michele
Taron, Miguel
Collini, Paola
Ranchere-Vince, Dominique
Garcia del Muro, Xavier
Grignani, Giovanni
Dumont, Sarah
Martinez-Trufero, Javier
Palmerini, Emanuela
Hindi, Nadia
Sebio, Ana
Dopazo, Joaquin
Dei Tos, Angelo Paolo
LeCesne, Axel
Blay, Jean-Yves
Cruz, Josefina

January 2019

Background: A solitary fibrous tumour is a rare soft-tissue tumour with three clinicopathological va...

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour : a multicentre, single-arm, phase 2 trial

J. Martin-Broto
S. Stacchiotti
A. Lopez-Pousa
A. Redondo
D. Bernabeu
E. de Alava
P.G. Casali
A. Italiano
A. Gutierrez
D.S. Moura
M. Pe&#241
J. Diaz-Martin
M. Biscuola
M. Taron
P. Collini
D. Ranchere-Vince
X. Garcia del Muro
G. Grignani
S. Dumont
J. Martinez-Trufero
E. Palmerini
N. Hindi
A. Sebio
J. Dopazo
A.P. Dei Tos
A. Lecesne
J. Blay
J. Cruz

January 2019

Background: A solitary fibrous tumour is a rare soft-tissue tumour with three clinicopathological va...

Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour

Stacchiotti S.
Tortoreto M.
Baldi G. G.
Grignani G.
Toss A.
Badalamenti G.
Cominetti D.
Morosi C.
Dei Tos A. P.
Festinese F.
Fumagalli E.
Provenzano S.
Gronchi A.
Pennacchioli E.
Negri T.
Dagrada G. P.
Spagnuolo R. D.
Pilotti S.
Casali P. G.
Zaffaroni N.

January 2014

Background To explore the activity of pazopanib in solitary fibrous tumour (SFT). Patients and metho...

A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans

Delyon, Julie
Porcher, Raphael
Battistella, Maxime
Meyer, Nicolas
Adamski, Henri
Bertucci, F.
Guillot, Bernard
Jouary, Thomas
Leccia, Marie-Thérèse
Dalac, Sophie
Mortier, Laurent
Ghrieb, Zineb
da Meda, Laetitia
Vicaut, Eric
Pedeutour, Florence
Mourah, Samia
Lebbe, Celeste

April 2021

International audienceDermatofibrosarcoma protuberans (DFSP) is a soft-tissue sarcoma characterized ...

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial

November 2020

none30siBackground: Extraskeletal myxoid chondrosarcoma is a rare sarcoma with low sensitivity to cy...

Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience.

Levard, Alice
Derbel, Olfa
Méeus, Pierre
Ranchère, Dominique
Ray-Coquard, Isabelle
Blay, Jean-Yves
Cassier, Philippe

January 2013

International audienceBACKGROUND: Solitary Fibrous Tumor is a rare type of soft tissue tumor of inte...

Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma: Results of a retrospective multi-institutional case series.

June 2017

none20openAnna Maria Frezza; Naofumi Asano; Robin Jones; Ravin Ratan; Pawel Teterycz; Hans Gelderblo...

Preoperative therapy with pazopanib in high-risk soft tissue sarcoma : a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)

Ronellenfitsch, Ulrich
Dimitrakopoulou-Strauss, Antonia
Jakob, Jens
Kasper, Bernd
Nowak, Kai
Pilz, Lothar R.
Attenberger, Ulrike
Gaiser, Timo
Egerer, Gerlinde
Fröhling, Stefan
Derigs, Hans-Günter
Schwarzbach, Matthias
Hohenberger, Peter

January 2016

Introduction: For resectable soft tissue sarcoma (STS), radical surgery, usually combined with radio...

Doxorubicin plus dacarbazine (DTIC) in advanced solitary fibrous tumor (SFT): An Italian retrospective case series analysis.

June 2016

none13nononeMaristella Saponara; Bruno Vincenzi; Giuseppe Badalamenti; Carlo Morosi; Silvana Pilotti...

Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072

Kasper, B.
Sleijfer, S.
Litiere, S.
Marreaud, S.
Verweij, J.
Hodge, R.A.
Bauer, S.
Kerst, J.M.
Graaf, W.T.A. van der

January 2014

BACKGROUND: Pazopanib recently received approval for the treatment of certain soft tissue sarcoma (S...

Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

Sleijfer, Stefan
Ray-Coquard, I
Papai, Z
le Cesne, A
Scurr, M
Schoffski, P
Collin, F
Pandite, L
Marreaud, S
De Brauwer, A
Glabbeke, M
Verweij, Jaap
Blay, JY

January 2009

Purpose Given the importance of angiogenesis in soft tissue sarcoma (STS), pazopanib, an oral angiog...

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study

SEZGİN GÖKSU, SEMA
PAYDAŞ, SEMRA
Akgul, Fahri
Derin, Sumeyye
Turhal, Serdar
Artac, Mehmet
Dal, Pinar
Sunar, Veli
Seker, Mehmet Metin
Gunaydin, Ulug Mutlu
Ozveren, Ahmet
Bahceci, Aykut
Sakalar, Teoman
Sahin, Suleyman
Koral, Lokman
Acar, Ramazan
Unal, Olcun Umit
Besiroglu, Mehmet
Erdem, Dilek
Demir, Hacer
Ozkul, Ozlem
Sakin, Abdullah
Gumusay, Ozge
Cinkir, Havva Yesil
Menekse, Serkan
Guc, Zeynep Gulsum
Karaca, Mustafa
Demiray, Atike Gokcen
Ozyukseler, Deniz Tataroglu
Erol, Cihan
Yekeduz, Emre
Ergun, Yakup
BİLİCİ, Ahmet
Koca, Sinan
Karaagac, Mustafa
Aydin, Sabin Goktas
Eraslan, Emrah
Kaplan, Muhammed Ali
Ocak, Birol

September 2023

Aim: Description of patient characteristics, effectiveness and safety in Turkish patients treated wi...

International single-arm phase II trial of pazopanib in advanced extraskeletal myxoid chondrosarcoma: A Collaborative Spanish (GEIS), Italian (ISG) and French (FSG) Sarcoma Groups study.

June 2017

none20sinoneSilvia Stacchiotti; Stefano Ferrari; Andres Redondo; Emanuela Palmerini; Nadia Hindi; M....

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial

Martin-Broto, Javier
Stacchiotti, Silvia
Lopez-Pousa, Antonio
Redondo, Andres
Bernabeu, Daniel
de Alava, Enrique
Casali, Paolo G
Italiano, Antoine
Gutierrez, Antonio
Moura, David S
Peña-Chilet, Maria
Diaz-Martin, Juan
Biscuola, Michele
Taron, Miguel
Collini, Paola
Ranchere-Vince, Dominique
Garcia del Muro, Xavier
Grignani, Giovanni
Dumont, Sarah
Martinez-Trufero, Javier
Palmerini, Emanuela
Hindi, Nadia
Sebio, Ana
Dopazo, Joaquin
Dei Tos, Angelo Paolo
LeCesne, Axel
Blay, Jean-Yves
Cruz, Josefina

January 2019

Background: A solitary fibrous tumour is a rare soft-tissue tumour with three clinicopathological va...

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour : a multicentre, single-arm, phase 2 trial

J. Martin-Broto
S. Stacchiotti
A. Lopez-Pousa
A. Redondo
D. Bernabeu
E. de Alava
P.G. Casali
A. Italiano
A. Gutierrez
D.S. Moura
M. Pe&#241
J. Diaz-Martin
M. Biscuola
M. Taron
P. Collini
D. Ranchere-Vince
X. Garcia del Muro
G. Grignani
S. Dumont
J. Martinez-Trufero
E. Palmerini
N. Hindi
A. Sebio
J. Dopazo
A.P. Dei Tos
A. Lecesne
J. Blay
J. Cruz

January 2019

Background: A solitary fibrous tumour is a rare soft-tissue tumour with three clinicopathological va...

Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour

Stacchiotti S.
Tortoreto M.
Baldi G. G.
Grignani G.
Toss A.
Badalamenti G.
Cominetti D.
Morosi C.
Dei Tos A. P.
Festinese F.
Fumagalli E.
Provenzano S.
Gronchi A.
Pennacchioli E.
Negri T.
Dagrada G. P.
Spagnuolo R. D.
Pilotti S.
Casali P. G.
Zaffaroni N.

January 2014

Background To explore the activity of pazopanib in solitary fibrous tumour (SFT). Patients and metho...

A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans

Delyon, Julie
Porcher, Raphael
Battistella, Maxime
Meyer, Nicolas
Adamski, Henri
Bertucci, F.
Guillot, Bernard
Jouary, Thomas
Leccia, Marie-Thérèse
Dalac, Sophie
Mortier, Laurent
Ghrieb, Zineb
da Meda, Laetitia
Vicaut, Eric
Pedeutour, Florence
Mourah, Samia
Lebbe, Celeste

April 2021

International audienceDermatofibrosarcoma protuberans (DFSP) is a soft-tissue sarcoma characterized ...

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial

November 2020

none30siBackground: Extraskeletal myxoid chondrosarcoma is a rare sarcoma with low sensitivity to cy...

Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience.

Levard, Alice
Derbel, Olfa
Méeus, Pierre
Ranchère, Dominique
Ray-Coquard, Isabelle
Blay, Jean-Yves
Cassier, Philippe

January 2013

International audienceBACKGROUND: Solitary Fibrous Tumor is a rare type of soft tissue tumor of inte...

Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma: Results of a retrospective multi-institutional case series.

June 2017

none20openAnna Maria Frezza; Naofumi Asano; Robin Jones; Ravin Ratan; Pawel Teterycz; Hans Gelderblo...

Preoperative therapy with pazopanib in high-risk soft tissue sarcoma : a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)

Ronellenfitsch, Ulrich
Dimitrakopoulou-Strauss, Antonia
Jakob, Jens
Kasper, Bernd
Nowak, Kai
Pilz, Lothar R.
Attenberger, Ulrike
Gaiser, Timo
Egerer, Gerlinde
Fröhling, Stefan
Derigs, Hans-Günter
Schwarzbach, Matthias
Hohenberger, Peter

January 2016

Introduction: For resectable soft tissue sarcoma (STS), radical surgery, usually combined with radio...

Doxorubicin plus dacarbazine (DTIC) in advanced solitary fibrous tumor (SFT): An Italian retrospective case series analysis.

June 2016

none13nononeMaristella Saponara; Bruno Vincenzi; Giuseppe Badalamenti; Carlo Morosi; Silvana Pilotti...

Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072

Kasper, B.
Sleijfer, S.
Litiere, S.
Marreaud, S.
Verweij, J.
Hodge, R.A.
Bauer, S.
Kerst, J.M.
Graaf, W.T.A. van der

January 2014

BACKGROUND: Pazopanib recently received approval for the treatment of certain soft tissue sarcoma (S...

Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

Sleijfer, Stefan
Ray-Coquard, I
Papai, Z
le Cesne, A
Scurr, M
Schoffski, P
Collin, F
Pandite, L
Marreaud, S
De Brauwer, A
Glabbeke, M
Verweij, Jaap
Blay, JY

January 2009

Purpose Given the importance of angiogenesis in soft tissue sarcoma (STS), pazopanib, an oral angiog...

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study

SEZGİN GÖKSU, SEMA
PAYDAŞ, SEMRA
Akgul, Fahri
Derin, Sumeyye
Turhal, Serdar
Artac, Mehmet
Dal, Pinar
Sunar, Veli
Seker, Mehmet Metin
Gunaydin, Ulug Mutlu
Ozveren, Ahmet
Bahceci, Aykut
Sakalar, Teoman
Sahin, Suleyman
Koral, Lokman
Acar, Ramazan
Unal, Olcun Umit
Besiroglu, Mehmet
Erdem, Dilek
Demir, Hacer
Ozkul, Ozlem
Sakin, Abdullah
Gumusay, Ozge
Cinkir, Havva Yesil
Menekse, Serkan
Guc, Zeynep Gulsum
Karaca, Mustafa
Demiray, Atike Gokcen
Ozyukseler, Deniz Tataroglu
Erol, Cihan
Yekeduz, Emre
Ergun, Yakup
BİLİCİ, Ahmet
Koca, Sinan
Karaagac, Mustafa
Aydin, Sabin Goktas
Eraslan, Emrah
Kaplan, Muhammed Ali
Ocak, Birol

September 2023

Aim: Description of patient characteristics, effectiveness and safety in Turkish patients treated wi...

Multi-institutional European single-arm phase II trial of pazopanib in advanced malignant/dedifferentiated solitary fibrous tumors (SFT): A collaborative Spanish (GEIS), Italian (ISG), and French (FSG) sarcoma groups study.

Abstract

Extracted data

Multi-institutional European single-arm phase II trial of pazopanib in advanced malignant/dedifferentiated solitary fibrous tumors (SFT): A collaborative Spanish (GEIS), Italian (ISG), and French (FSG) sarcoma groups study.

Abstract

Extracted data

Related items

Related items